<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0003074'>Hyperglycemia</z:hpo> aggravates brain injury induced by focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinase (MAPK) members extracellular-signal regulated kinase (Erk) and c-Jun N-terminal kinase (JNK) have been proposed as mediators of ischemic brain injury, and Erk is strongly activated by combined <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and transient global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>It is unclear whether similar MAPK activation appears in focal <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> with concomitant <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>DESIGN: <z:hpo ids='HP_0003074'>Hyperglycemia</z:hpo> was induced in rats by an intraperitoneal bolus of <z:chebi fb="105" ids="17234">glucose</z:chebi> (2 g kg(-1)) </plain></SENT>
<SENT sid="4" pm="."><plain>The rats were then subjected to 90 min of transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="5" pm="."><plain>Erk and JNK activation were investigated with immunofluorescence and Western blot along with <z:mpath ids='MPATH_124'>infarct</z:mpath> size measurement based on tetrazolium staining and neurological score </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The hyperglycemic rats showed increased tissue damage and impaired neurological performance after 1 day compared with controls </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> was generally moderate (&lt; 15 mM) </plain></SENT>
<SENT sid="8" pm="."><plain>Erk activation was increased after 30 min of reperfusion in the ischemic cortex of the hyperglycemic rats, while JNK activation was present on the contralateral side </plain></SENT>
<SENT sid="9" pm="."><plain>Phospho-Erk immunofluorescence revealed marked neuronal activation of Erk in the ischemic cortex of hyperglycemic rats compared with controls </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Besides confirming the detrimental effects of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> on focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion, this study shows that <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> strongly activates the pathogenic mediator Erk in the ischemic brain in the early phase of reperfusion </plain></SENT>
<SENT sid="11" pm="."><plain>JNK activation at this stage is present in the nonischemic hemisphere </plain></SENT>
<SENT sid="12" pm="."><plain>The functional relevance of these findings needs further investigation </plain></SENT>
</text></document>